News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,047 Results
Type
Article (40498)
Company Profile (258)
Press Release (660291)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204644)
Career Advice (2035)
Deals (35471)
Drug Delivery (95)
Drug Development (81208)
Employer Resources (173)
FDA (16209)
Job Trends (14930)
News (345928)
Policy (32597)
Tag
Academia (2586)
Accelerated approval (5)
Adcomms (21)
Allergies (85)
Alliances (49583)
ALS (90)
Alzheimer's disease (1394)
Antibody-drug conjugate (ADC) (125)
Approvals (16212)
Artificial intelligence (256)
Autoimmune disease (21)
Automation (16)
Bankruptcy (361)
Best Places to Work (11693)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (183)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2257)
Cardiovascular disease (174)
Career advice (1699)
Career pathing (30)
CAR-T (152)
Cell therapy (425)
Cervical cancer (19)
Clinical research (66086)
Collaboration (835)
Company closure (1)
Compensation (533)
Complete response letters (20)
COVID-19 (2596)
CRISPR (40)
C-suite (244)
Cystic fibrosis (100)
Data (2206)
Decentralized trials (2)
Denatured (18)
Depression (49)
Diabetes (270)
Diagnostics (6373)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86699)
Editorial (38)
Employer branding (22)
Employer resources (147)
Events (112728)
Executive appointments (724)
FDA (17476)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (104)
Generative AI (19)
Gene therapy (302)
GLP-1 (715)
Government (4434)
Grass and pollen (4)
Guidances (67)
Healthcare (18860)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2738)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (97)
Interviews (320)
IPO (16528)
IRA (40)
Job creations (3652)
Job search strategy (1440)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (17)
Legal (7923)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (306)
MASH (67)
Medical device (13404)
Medtech (13409)
Mergers & acquisitions (19489)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (94)
Neuropsychiatric disorders (30)
Neuroscience (1946)
NextGen: Class of 2025 (6548)
Non-profit (4499)
Now hiring (39)
Obesity (365)
Opinion (205)
Ovarian cancer (75)
Pain (91)
Pancreatic cancer (83)
Parkinson's disease (152)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (46)
People (57476)
Pharmaceutical (65)
Pharmacy benefit managers (18)
Phase I (20586)
Phase II (29101)
Phase III (21676)
Pipeline (1206)
Policy (140)
Postmarket research (2567)
Preclinical (8776)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (379)
Real estate (5937)
Recruiting (65)
Regulatory (22316)
Reports (46)
Research institute (2344)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (73)
Series A (132)
Series B (86)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3602)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (31)
Vaccines (690)
Venture capitalists (41)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (156)
Last 7 days (930)
Last 30 days (2628)
Last 365 days (32863)
2025 (10768)
2024 (35317)
2023 (40180)
2022 (51265)
2021 (55818)
2020 (54187)
2019 (46644)
2018 (35129)
2017 (32199)
2016 (31620)
2015 (37692)
2014 (31466)
2013 (26494)
2012 (28684)
2011 (29384)
2010 (27420)
Location
Africa (727)
Alabama (53)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38005)
Australia (6224)
California (6142)
Canada (2017)
China (526)
Colorado (266)
Connecticut (274)
Delaware (148)
Europe (81763)
Florida (914)
Georgia (206)
Idaho (57)
Illinois (545)
India (26)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (894)
Massachusetts (4592)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1728)
New Mexico (28)
New York (1750)
North Carolina (969)
North Dakota (8)
Northern California (2684)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1100)
South Carolina (23)
South Dakota (1)
Southern California (2304)
Tennessee (102)
Texas (908)
United States (23186)
Utah (180)
Virginia (146)
Washington D.C. (64)
Washington State (553)
West Virginia (3)
Wisconsin (54)
701,047 Results for "gate neurosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
Gate Neurosciences to Share New Data and Research Insights on its Synaptic Function Molecules with Multiple Posters at 2024 ASCP Annual Meeting
Gate Neurosciences today announced upcoming activities at the 2024 annual meeting of the American Society of Clinical Psychopharmacology (ASCP), being held in Miami Beach, FL, from May 28-31, 2024.
May 15, 2024
·
4 min read
Press Releases
Gate Neurosciences and University of Pittsburgh Collaborate to Initiate Phase 2 Trial Combining Apimostinel with Digital Therapeutic for Depression
December 3, 2024
·
3 min read
Press Releases
Gate Neurosciences Presents New Data and Insights Highlighting Unique Pharmacology of Synaptic Function Modulators at the 2024 ACNP Annual Meeting
December 12, 2024
·
5 min read
Business
Gate Neurosciences Announces Clinical Collaboration with Beacon Biosignals to Advance Precision EEG Biomarkers in Major Depressive Disorder
Gate Neurosciences today announced a strategic collaboration with Beacon Biosignals to further advance the use of electroencephalogram (EEG) biomarkers across the company’s clinical pipeline in neuropsychiatry and cognition.
January 24, 2024
·
4 min read
Press Releases
IonQ Reaches Important Milestone in Achieving Faster Quantum Gates for Quantum Computing and Networking
March 5, 2025
·
6 min read
Press Releases
Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
April 2, 2025
·
10 min read
Neurodegenerative disease
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, which today began a rolling BLA for accelerated approval.
April 2, 2025
·
5 min read
·
Dan Samorodnitsky
Drug Development
Gate Neurosciences Announces Positive Topline Human EEG Biomarker Results Demonstrating Dose-Dependent Target Activation in Phase 1 Study of Apimostinel
Gate Neurosciences, a clinical-stage biotechnology company using precision medicine approaches to develop next-generation neuroscience therapies, today announced positive topline qEEG biomarker and safety results from its Phase 1 multiple ascending dose study of apimostinel in healthy volunteers.
November 7, 2023
·
4 min read
Press Releases
Senti Bio to Showcase SENTI-202 Clinical Data and Novel Logic Gated Gene Circuit Mechanism of Action in Oral and Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 3, 2025
·
7 min read
1 of 70,105
Next
